HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty

This article was originally published in The Rose Sheet

Executive Summary

Firm forms Coty Middle East FZCO, a joint venture with Michel Chaloub Trading Co. based out of Dubai, company announces July 23. A Michel Chaloub affiliate has been the esclusive distributor of Coty Beauty and Lancaster Group products in the Middle East for seven years, Coty notes. "Our strategy is to build a leadership position for Coty in new areas and [we] realized that Coty could capitalize on the true market potential in the Middle East, a region which can give us access to a large consumer market," Coty CEO Bernd Beetz said. Firm has appointed Hani Jabbour as General Manager of the new subsidiary. Exec previously was General Manager of Fitra International Fze, a fashion accessory and fragrance distributor, according to Coty...

You may also be interested in...



Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.

Sanofi Skates To Where The Puck Is With Immunology

The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.

Pipeline Watch: Five Approvals And 23 Phase III Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012335

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel